EW Healthcare Partners
20
33M
13
0.53
5
0.35
5
- Areas of investment
Summary
We can highlight the next thriving fund investment areas, such as Information Technology, Health Care. The fund has specific favorite in a number of founders of portfolio startups. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. Among the various public portfolio startups of the fund, we may underline Cota Healthcare, EyePoint Pharmaceuticals, Encore Dermatology
The standard case for the fund is to invest in rounds with 4-5 partakers. Despite the EW Healthcare Partners, startups are often financed by Med-Metrix, Horizon Blue Cross Blue Shield of New Jersey, Tennenbaum Capital Partners. The meaningful sponsors for the fund in investment in the same round are SEDCO Capital, SEB Private Equity, Rosalind Advisors. In the next rounds fund is usually obtained by Medivate Partners.
The fund is constantly included in 2-6 investment rounds annually. The increased amount of exits for fund were in 2014. Comparing to the other companies, this EW Healthcare Partners performs on 4 percentage points more the average number of lead investments. The common things for fund are deals in the range of 10 - 50 millions dollars. The top activity for fund was in 2019. Speaking about the real fund results, this VC is 47 percentage points more often commits exit comparing to other organizations.
Besides them, we counted 8 critical employees of this fund in our database.
Investments analytics
Analytics
- Total investments
- 20
- Lead investments
- 5
- Exits
- 5
- Rounds per year
- 0.53
- Follow on index
- 0.35
- Investments by industry
- Health Care (13)
- Biotechnology (12)
- Medical (8)
- Medical Device (8)
- Manufacturing (5) Show 12 more
- Investments by region
-
- United States (17)
- Canada (3)
- Peak activity year
- 2020
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 23
- Avg. valuation at time of investment
- 67M
- Group Appearance index
- 0.70
- Avg. company exit year
- 8
- Avg. multiplicator
- 3.28
- Strategy success index
- 0.30
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| COTA Healthcare | 21 Feb 2018 | Biotechnology, Health Care, Life Science | Late Stage Venture | 40M | United States, New York, New York |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.